Our Story

OUR STORY

Industry Pioneers Leading
You into the Future

Acara Partners is proud to be the first full-service business consulting firm dedicated to the aesthetic medical industry. Over the past two decades, Acara Partners has worked with more than 350 aesthetic medical practices and developed more than 180 med spas nationwide, creating business plans that drive success.

Our story begins over 30 years ago in 1996 when our co-founder and CEO Francis X Acunzo and his wife and co-founder Colleen launched the very first medical spa, kickstarting the medical aesthetic movement that has brought us here today.

OUR HISTORY

Francis and Colleen Acunzo in 1996

1996

In 1996, Francis Acunzo and Colleen Acunzo launched the very first med spa through a business venture with their Boston-based spa company and Candela Corporation, a leading cosmetic laser company.

Former Acara logo. Acara Development, Management & Marketing

2004

Francis and Colleen launched Acara Partners in 2004 to become the first business consulting agency dedicated to the aesthetic medical industry.

Francis and Colleen Acunzo in 2015

2008

In 2008, Francis and Colleen expanded Acara Partners to include marketing strategy, making it the first full-service marketing agency dedicated to the aesthetic medical industry.

OUR MISSION

Acara Partners is dedicated to providing full-service, tailored solutions that meet each one of our clients’ needs. Our in-house team of business consultants are committed to helping our clients flourish, offering expertise in business development, operations support, sales training, marketing strategy and implementation, and more. Whether you’re partnering with us to start your own med spa, enhance your existing practice or elevate your business efforts, our goal will always be to bring your unique vision to life with proven results and success every time.

acara logo mark

LET’S TALK ABOUT YOUR
MED SPA BUSINESS

PARTNER WITH US.

Learn More About Starting Your Own Med Spa or Growing Your Aesthetic Medical Practice.